William K. Heiden
2016
In 2016, William K. Heiden earned a total compensation of $3M as Chief Executive Officer at AMAG Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $543,500 |
|---|---|
| Option Awards | $931,787 |
| Salary | $632,107 |
| Stock Awards | $906,480 |
| Other | $7,950 |
| Total | $3,021,824 |
Heiden received $931.8K in option awards, accounting for 31% of the total pay in 2016.
Heiden also received $543.5K in non-equity incentive plan, $632.1K in salary, $906.5K in stock awards and $8K in other compensation.
Rankings
In 2016, William K. Heiden's compensation ranked 3,154th out of 14,075 executives tracked by ExecPay. In other words, Heiden earned more than 77.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,154 out of 14,075 | 78th |
Division Manufacturing | 1,092 out of 5,486 | 80th |
Major group Chemicals And Allied Products | 321 out of 1,900 | 83rd |
Industry group Drugs | 234 out of 1,543 | 85th |
Industry Pharmaceutical Preparations | 181 out of 1,173 | 85th |
Source: SEC filing on April 20, 2017.
Heiden's colleagues
We found five more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2016.
2016
Nicholas Grund
AMAG Pharmaceuticals
Chief Commercial Officer
2016
Frank Thomas
AMAG Pharmaceuticals
Chief Operating Officer
2016
Edward Myles
AMAG Pharmaceuticals
Chief Financial Officer
2016
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2016
Joseph Vittiglio
AMAG Pharmaceuticals